Howden India develops Cancer Care Group Policy; AstraZeneca India adopts cover for employees Read more
Dr Reddy’s registers PD-1 inhibitor for recurrent or metastatic nasopharyngeal carcinoma in South Africa Read more
India to build future-ready drug regulatory framework to accelerate healthcare innovation, Says J P Nadda Read more